ArticleNPJ digital medicine2026
Automated detection of new cerebral infarctions and prognostic implications using deep learning on serial MRI.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We developed and externally validated a deep learning model to automatically detect new ischemic lesions on serial FLAIR MRI scans in patients with stroke. Manual interpretation of follow-up imaging is labor-intensive and variable, and silent brain infarctions (SBIs) are frequently missed despite their prognostic importance. Using 25,451 paired slices from 1055 patients across two hospitals, we trained a convolutional neural network with supervised contrastive learning to classify new lesion occurrence. The model achieved an area under the receiver operating characteristic curve of 0.89 in both internal and external validation cohorts. To evaluate clinical relevance, we further analyzed an independent asymptomatic cohort of 307 patients with a median follow-up of two years. Patients classified as SBI-positive by the model showed a significantly higher risk of subsequent symptomatic stroke than those without SBI. In multivariable Cox regression adjusted for age and major vascular risk factors, model-positive patients had a 3.8-fold increased risk of stroke recurrence. These findings indicate that AI can identify clinically meaningful SBIs that are under-recognized in routine practice and independently associated with stroke recurrence. Automated lesion detection may provide a reproducible imaging biomarker for risk stratification, supporting standardized interpretation of follow-up MRI and informing secondary stroke prevention strategies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.